As shown by cumulative data of cytofluorimetric analyses obtained from RA patients and reported in Figure 3A, PE-EVOO treatment reduced the percentage of RA PBMCs producing both TNF-α and IL-1β with respect to untreated RA PBMCs. This evidence concerns the gene TNF and rheumatoid arthritis.